Patents by Inventor James E. K. Hildreth

James E. K. Hildreth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220193166
    Abstract: Artificial cervical fluid is disclosed that contains a mucilaginous extract from the okra plant. The mucilaginous extract can be produced using a hot aqueous extractant or cold extraction process followed by separation of larger particles from the extract. The extract finds many uses, for example as a sperm storage medium, a sperm freezing medium, a sexual lubricant, an artificial insemination medium, and an in vitro fertilization medium.
    Type: Application
    Filed: December 28, 2021
    Publication date: June 23, 2022
    Inventors: Anthony E. ARCHIBONG, G. William BATES, Elochukwu J. Ezekakpu, Lorin W. SIMON, James E.K. Hildreth
  • Patent number: 11241466
    Abstract: Artificial cervical fluid is disclosed that contains a mucilaginous extract from the okra plant. The mucilaginous extract can be produced using a hot aqueous extractant or cold extraction process followed by separation of larger particles from the extract. The extract finds many uses, for example as a sperm storage medium, a sperm freezing medium, a sexual lubricant, an artificial insemination medium, and an in vitro fertilization medium.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: February 8, 2022
    Inventors: Anthony E. Archibong, G. William Bates, Elochukwu J. Ezekakpu, Lorin W. Simon, James E. K. Hildreth
  • Publication number: 20210228664
    Abstract: Artificial cervical fluid is disclosed that contains a mucilaginous extract from the okra plant. The mucilaginous extract can be produced using a hot aqueous extractant or cold extraction process followed by separation of larger particles from the extract. The extract finds many uses, for example as a sperm storage medium, a sperm freezing medium, a sexual lubricant, an artificial insemination medium, an in vitro fertilization medium, and methods for treating and/or preventing infection, replication, and transmission of viruses, such as sexually transmitted viruses.
    Type: Application
    Filed: March 21, 2021
    Publication date: July 29, 2021
    Applicant: Meharry Medical College
    Inventors: Anthony E. Archibong, Bindong Liu, G. William Bates, Elochukwu J. Ezekakpu, Lorin W. Simon, James E.K. Hildreth
  • Publication number: 20190201464
    Abstract: Artificial cervical fluid is disclosed that contains a mucilaginous extract from the okra plant. The mucilaginous extract can be produced using a hot aqueous extractant or cold extraction process followed by separation of larger particles from the extract. The extract finds many uses, for example as a sperm storage medium, a sperm freezing medium, a sexual lubricant, an artificial insemination medium, and an in vitro fertilization medium.
    Type: Application
    Filed: March 6, 2019
    Publication date: July 4, 2019
    Inventors: Anthony E. ARCHIBONG, G. William BATES, Elochukwu J. Ezekakpu, Lorin W. SIMON, James E.K. Hildreth
  • Publication number: 20040053892
    Abstract: The invention provides enantiomers of a joene and derivtives of Z(−)-ajoene. The derivative of Z(−)-ajoene are useful for modulating integrin-mediated functions, for treating disorders, diseases or conditions in which integrins play a role, and for treating tissues to improve their condition for a subsequent use, such as transplantation.
    Type: Application
    Filed: June 17, 2003
    Publication date: March 18, 2004
    Inventors: John B Davidson, Alexander V Tatarintsev, Ali S Turgiev, James E K Hildreth
  • Patent number: 6495315
    Abstract: The infectivity of a population of enveloped viruses which comprise a glycosylphosphatidylinositol-anchored protein in their membrane can be reduced by employing certain toxins such as aerolysin, alpha toxin of Clostridium septicum, or enterolobin. Toxins which bind to glycosylphosphatidylinositol-anchored proteins inactivate such viruses. The toxins can be used to produce attenuated viral vaccines, to purge blood products, cells, or tissues of such viruses, and to detect viruses in samples.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: December 17, 2002
    Assignee: The Johns Hopkins University
    Inventors: James E. K. Hildreth, Dzung H. Nguyen, James Thomas Buckley
  • Publication number: 20020012671
    Abstract: The infectivity of a population of enveloped viruses which comprise a glycosylphosphatidylinositol-anchored protein in their membrane can be reduced by employing certain toxins such as aerolysin, alpha toxin of Clostridium septicum, or enterolobin. Toxins which bind to glycosylphosphatidylinositol-anchored proteins inactivate such viruses. The toxins can be used to produce attenuated viral vaccines, to purge blood products, cells, or tissues of such viruses, and to detect viruses in samples.
    Type: Application
    Filed: January 12, 2001
    Publication date: January 31, 2002
    Inventors: James E.K. Hildreth, Dzung H. Nguyen, James Thomas Buckley